NCT03478761Recruiting
24-Hydroxylase Deficiency and CYP24A1 Mutation Patient Registry
Mayo Clinic
Start Date
10/19/2017
Completion Date
12/1/2030
Summary
You are being asked to take part in this research registry because you or your family member is suspected to have a 24-hydroxylase deficiency.
Detailed Description
In this registry we propose to establish and maintain a registry of suspected and confirmed patients with 24 hydroxylase deficiency in an effort to collect data for further investigation. This would be the first and only known registry of its kind. These resources would be made widely available to clinicians and research scientists within Mayo to stimulate advances in the diagnosis and treatment of patients with this disease.
Eligibility Criteria
Age Range: No minimum to No maximum
Inclusion Criteria:
Patients who have undergone genetic testing for a CYP24A1 mutation with at least 3 of the following:
* Urinary Stone Disease
* Nephrocalcinosis
* Metabolic Bone Disease
* Serum Calcium \>/= 9.6 mg/dL
* Parathyroid hormone (PTH) \< 30 pg/mL
* 1,25-dihydroxyvitamin D \> 40 pg/mL OR a family member of a patient who meets the above criteria
Exclusion Criteria:
Patients who have tested negative for a CYP24A1 mutation with an alternative diagnosis that might explain hypercalcemia/hypercalciuria/stone disease:
* Sarcoidosis
* Lymphoma
* Tuberculosis
* Fungal infections
* Excessive exogenous calcium or vitamin D intake
Conditions
24-hydroxylase Deficiency
Locations
Mayo Clinic
Rochester, Minnesota 55905
United States